The inhibition of TRAP1 induction increases the apoptosis process in prostate cancer cells, which suggests that TRAP1 inhibitors (gamitrinibs (GA), mitochondrial matrix inhibitors) can be used in therapy for patients with advanced prostate glands [108]. Here, TRAP1 is linked to prostate carcinoma.